Deferasirox-induced robust and dose-dependent reversal of anemia in a patient with variants in the TRIB2 and ABCB6 genes.

Authors	Julia Stomper, Paulina Richter-Pechanska, Dietmar Pfeifer, Immacolata Andolfo, Achille Iolascon, Martina U Muckenthaler, Michael Lübbert
Journal	Blood advances (Blood Adv) Vol. 6 Issue 11 Pg. 3551-3555 (06 14 2022) ISSN: 2473-9537 [Electronic] United States
PMID	35320338 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References	ABCB6 protein, human ATP-Binding Cassette Transporters Iron Chelating Agents Calcium-Calmodulin-Dependent Protein Kinases TRIB2 protein, human Deferasirox
Topics	ATP-Binding Cassette Transporters Anemia Calcium-Calmodulin-Dependent Protein Kinases (genetics, metabolism) Deferasirox (therapeutic use) Humans Iron Chelating Agents

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!